ProtonDx's core technology builds on years of innovative research on diagnostics and sample processing, fuelled by unique collaborations between engineering, medicine and molecular biology. The spinout company was founded in 2020 at Imperial College London.
The team also developed Lacewing (Digital Diagnostics platform using Lab-on-chip technology) and the Dragonfly PoC diagnostic device, which was used at the 2022 Winter Olympics and Commonwealth Games. Today, they are continuing to innovate and develop new molecular diagnostic and sample extraction technologies which can be used anywhere.
Imperial researchers working on ProtonDX
- Dr Jesus Rodriguez Manzano (Co-Founder and Chief Scientific Officer)
- Professor Pantelis Georgiou (Co-Founder and Director)
- Dr Nick Moser (Co-Founder and Chief Technology Officer)
- Dr Ivana Pennisi
